BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA
SHANGHAI, Feb. 10, 2025 /PRNewswire/ -- On December 19, 2024, BioRay Pharmaceutical Co., Ltd. ("BioRay") announced that the National Medical Products Administration (NMPA) has accepted the clinical trial application for its self-developed Class 1...
Forest City Receives One More Good News, Digital Status Empowers Regional Development
ISKANDAR PUTERI, Malaysia, Feb. 6, 2025 /PRNewswire/ -- In recent years, Malaysian government has elevated the digital economy to a national strategic height, aimed at attracting companies, talent, and investment. Aerial view of Forest City Island 1...
Harbour BioMed Receives NMPA IND Clearance for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 5, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody...
Four Seasons Education Receives Non-Compliance Letter from NYSE Regarding Holders Requirements
SHANGHAI, Feb. 3, 2025 /PRNewswire/ -- Four Seasons Education (Cayman) Inc. ("Four Seasons Education" or the "Company") (NYSE: FEDU), a tourism and education-related service provider in China, today announced that it has received a letter from the...
Axcelis Wins The 2024 SK hynix CSO Safety and Health Award
Award Recognizes Companies Who Achieve Highest Level of Safety BEVERLY, Mass., Feb. 3, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, has...
ICR Receives Unconditional ICROA Endorsement, Solidifying Commitment to High Integrity Carbon Credits
REYKJAVIK, Iceland, Jan. 31, 2025 /PRNewswire/ -- The International Carbon Registry (ICR) has received unconditional endorsement of its carbon crediting program by the International Carbon Reduction and Offset Alliance (ICROA).This achievement...
Clarity receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer
SYDNEY, Jan. 24, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and...
LightInTheBox Receives Non-compliance Letter from NYSE Regarding Market Capitalization
SINGAPORE, Jan. 24, 2025 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global online retailer focusing on proprietary apparel brands and design-driven collections tailored to evolving consumer...
TrinaTracker Vanguard 1P receives Bureau Veritas Carbon Footprint Verification
SHANGHAI, Jan. 20, 2025 /PRNewswire/ -- The Vanguard 1P trackers of TrinaTracker, a subsidiary of Trinasolar, have received Carbon Footprint Verification from the global inspections, certifications and laboratory testing provider Bureau Veritas. The...
MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The transdermal GFR (tGFR) methodology has been designed to be effective across the adult...